TOP JOURNAL OF CLINICAL BREAST CANCER SECRETS

Focused protein degradation is being explored in its place system in cancer, whereby the natural protein degradation process is co-opted for therapeutic functions. Not too long ago formulated novel molecules called proteolysis-targeting chimeras (PROTACs) are heterobifunctional molecules with two ligands joined by a linker. One ligand binds to the